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Long interspersed nuclear elements (LINE-1 or L1) are 
the most abundant retrotransposable elements accounting 
for nearly 17% of the human genome. These elements 
can be randomly incorporated in the genome, therefore 
having an important role in its plasticity and in generating 
structural genetic variants. It has been demonstrated that 
L1 retrotransposon activity may occasionally cause genetic 
diseases. To date, only four disease-causing L1 elements 
have been described in the dystrophin (DMD) gene; three 
inserted in exons 44, 48 and 67, in patients with a Duchenne 
muscular dystrophy (DMD) phenotype, and one detected 
in the 5´untranslated region, in two apparently unrelated 
Japanese families with X-linked dilated cardiomyopathy.
We report a 48 year old man with a clinical diagnosis 
of Becker muscular dystrophy (BMD), in 2001, without 
molecular confirmation by multiplex PCR and Southern-Blot 
analysis, and whose diagnosis was recently revisited because 
his daughter is considering pregnancy. A second molecular 
study, resorting to multiplex ligation-probe amplification 
(MLPA) analysis and genomic DMD gene sequencing, again 
failed to detect abnormalities. A new muscle biopsy showed 
dystrophic features with irregular labeling for dystrophin on 
immunohistochemical analysis, suggesting dystrophinopathy. 
With the intention of unveiling a genetic defect that 
might be refractory to the previous diagnostic techniques, 
muscle-derived DMD transcripts were sequenced in their 
entirety. Results revealed an insertion of 103 nucleotides 
between exons 51 and 52, which showed no homology to the 
gene’s reference sequence. Extensive bioinformatic analysis 
(homology search and splice-site/branch-point analysis) and 
sequential direct sequencing enabled the discovery of a deep-
intronic insertion of an L1 element, in intron 51. This extremely 
rare mutational event resulted in the partial exonization of the 
L1 plus 5 nucleotides of intron 51. In addition to the aberrant 
out-of-frame transcript, a residually expressed wild-type 
transcript was also detected, thereby explaining the milder 
phenotype in this patient.
To our knowledge this is the first report ever of 
dystrophinopathy caused by an intronically placed L1 
element. Besides representing an exceptional contribution 
towards widening the DMD gene mutation spectrum, this 
study highlights the importance of conducting mRNA studies 
in as yet uncharacterized BMD/DMD patients. This holds true 
even considering some of the most recent state-of-the-art 
screening approaches, based on next-generation sequencing 
technology, where this type of mutation may ultimately fail to 
be detected.
